Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

10 August 2005

Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience

Macaulay A C Onuigbo, Nnonyelum T C Onuigbo

Med Sci Monit 2005; 11(10): CR462-469 :: ID: 430303

Abstract

BACKGROUND: Worsening azotemia following initiation of angiotensin blockade(AB), in patients with CKD, RAS with/without precipitating factors is recognized. Small increases inserum creatinine following initiation of AB occur and must not warrant drug discontinuation. We anecdotallyhad observed improvement in CKD in patients with normal renal arteries and no precipitating factors,following termination of AB. The worldwide ESRD epidemic, coincident with increasing use of AB, promptedus to hypothesize a late-onset azotemia in such CKD patients. MATERIAL/METHODS: Over 30 months, 103 patientswith worsening azotemia, while on AB were evaluated. Ninety-seven patients with abnormal MRA and/or withprecipitating factors were excluded. In the remaining five, AB was discontinued, and GFR monitored. RESULTS:One male, four females, mean age 66.2 years. Three diabetic/hypertensives, one SLE/hypertensive, onediabetic/kidney transplant recipient. Mean stable AB, 25.2 months, (6-66 months). Mean follow up, 11.8months. One month following discontinuation of AB, GFR increased by a mean 45%. Mean serum creatininedecreased from 2.9+/-0.9 to 1.8+/-0.4 mg/dL (p=0.04). Uremic symptoms in 3, hyperkalemia in one, secondaryhyperparathyroidism in one, resolved. Two with anemia, now require less erythropoietin. CONCLUSIONS:We called this unrecognized potentially reversible late-onset worsening azotemia, occurring several monthsto years on stable AB, in CKD patients with normal renal arteries, without precipitating factors, late-onsetrenal failure from angiotensin blockade (LORFFAB). Pathophysiologically, the concept of microvascularRAS is invoked. The extent of LORFFAB, with millions of patients worldwide on AB, remains conjecturaland warrants further investigation.

Keywords: Angiotensin II Type 1 Receptor Blockers - adverse effects, Aged, 80 and over, angiotensin receptor antagonists, Angiotensin-Converting Enzyme Inhibitors - adverse effects, Blood Pressure, Creatinine - urine, Glomerular Filtration Rate, Kidney Failure, Chronic - urine, Prospective Studies, Uremia - physiopathology, Wisconsin

0 Comments

Editorial

04 June 2022 : Editorial  

Editorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?

Nahum Mendez-Sanchez, Shreya C. Pal
Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

DOI: 10.12659/MSM.937371

Med Sci Monit 2022; 28:e937371

In Press

27 Jun 2022 : Clinical Research  

Automatic Identification of Depression Using Facial Images with Deep Convolutional Neural Network

Med Sci Monit In Press; DOI: 10.12659/MSM.936409  

23 Jun 2022 : Clinical Research  

A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, w...

Med Sci Monit In Press; DOI: 10.12659/MSM.936706  

22 Jun 2022 : Clinical Research  

A Single-Center Study Comparing the Effects of Thoracic Spine Manipulation vs Mobility Exercises in 26 Offi...

Med Sci Monit In Press; DOI: 10.12659/MSM.937316  

21 Jun 2022 : Clinical Research  

Optimal Timing and Outcomes of Minimally Invasive Approach in Acute Biliary Pancreatitis

Med Sci Monit In Press; DOI: 10.12659/MSM.937016  

Most Viewed Current Articles

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Nov 2020 : Review article  

Long-Term Respiratory and Neurological Sequelae of COVID-19

DOI :10.12659/MSM.928996

Med Sci Monit 2020; 26:e928996

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750